Skip to content

Calibration of the Average Breathing Rate Measurement of the Cloud DX Pulsewave Health Monitor (PAD-2A) Device (CCV-3)

Calibration of the Average Breathing Rate Measurement of the Cloud DX Pulsewave Health Monitor (PAD-2A) Device (CCV-3)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04868630
Acronym
CCV-3
Enrollment
80
Registered
2021-05-03
Start date
2021-09-10
Completion date
2023-12-31
Last updated
2023-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Outpatients

Keywords

average breathing rate (breath per minute), vital sign monitoring, telemedicine, non-invasive device

Brief summary

The purpose of this study is to calibrate the average breathing rate measurement of the PAD-2A device to be within ±2 breaths per minute of clinical capnography breathing rate measurements.

Detailed description

The plan for this study is to calibrate the average breathing rate measurement of the PAD-2A device with the breathing rate measurement of a standard clinical capnography device. The data will be collected and analyzed in order to calibrate the PAD-2A device via the capnography measures by adjusting the device algorithm for the breathing rate measurements to be within ±2 breaths per minute. Additionally, the secondary objective of this study is to compare the clinical standard respiratory rate measurement of capnography with the respiratory rate measurements of other standard clinical respiratory devices (i.e. nasal pressure transducer, thermistor, and the respiratory inductance plethysmography (RIP) belts of the chest and abdomen).

Interventions

This is an observational study of the average breathing rate measurement of a non-invasive wrist cuff device. The purpose of this study is to calibrate the average breathing rate measurement of the Pulsewave Health Monitor (PAD-2A) wrist cuff device with the breathing rate measurement of a standard clinical capnography device. Additionally, we will also compare the average breathing rate measurement of the capnography device with other standard clinical respiratory devices (i.e. nasal pressure transducer, thermistor, and respiratory inductance plethysmography (RIP) belts of the chest and abdomen).

Sponsors

Cloud DX Inc.
CollaboratorINDUSTRY
Horizon Health Network
CollaboratorOTHER
Atlantic Sleep Center
CollaboratorUNKNOWN
New Brunswick Health Research Foundation
CollaboratorOTHER
Dalhousie University
CollaboratorOTHER
Cardiovascular Research New Brunswick
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults ≥ 19 years of age (minimum 30% male/female) * Wrist circumference between 13.5cm - 23cm (5.3 in. - 9.1in.) * Specifically for this test device, the wrist size of the consented participants will be distributed accordingly for a Gaussian distribution: Lowest Octile: ≥ 13.5cm to \< 14.7cm Lower Quarter: ≥ 13.5cm to \< 15.9cm Lower-Middle Quarter: ≥ 15.9cm to \< 18.3cm Upper-Middle Quarter: ≥ 18.3cm to \< 20.7cm Upper Quarter: ≥ 20.7cm to ≤ 23.0cm Highest Octile: ≥ 21.9cm to ≤ 23.0cm • Willing to volunteer to participate and to sign the study specific informed consent form

Exclusion criteria

* Wrist circumference less than 13.5cm (5.3 in.) or greater than 23cm (9.1 in) * Hand or body tremors * Canadian Cardiovascular Society (CCS) grade III or IV angina pectoris (chest pain) * Unexplained shortness of breath at rest * History of seizures (except childhood febrile seizures) * Epilepsy * History of unexplained syncope (fainting) * Pregnant * A musculoskeletal disorder that prevents a non-invasive device to be inflated/deflated on the arm * Unwilling to volunteer to participate and to sign the study specific informed consent form

Design outcomes

Primary

MeasureTime frameDescription
Breathing rateFrom the start of cuff deflation to the end of cuff deflation (approximately 60 seconds).Non-invasive Pulsewave Health Monitor (PAD-2A) wrist cuff device (breaths per minute)

Secondary

MeasureTime frameDescription
Breathing rateSimultaneous measurement with the PAD-2A wrist cuff device from the start of cuff deflation to the end of cuff deflation (approximately 60 seconds).Standard clinical respiratory inductance plethysmography (RIP) belts (breaths per minute)

Countries

Canada

Contacts

Primary ContactChristie Aguiar, PhD
christie.aguiar@clouddx.com506-977-2712
Backup ContactKeith R. Brunt, PhD
keith.brunt@dal.ca506-636-6974

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026